Skip to main
CLBS
CLBS logo

Caladrius Biosciences (CLBS) Market Capitalization Overview

Market Cap: $22.95M as of Aug 12, 2025

$22.95M
Past Month-$360.50K (1.55%)
As of Aug 12, 2025, Caladrius Biosciences (CLBS) has a market capitalization of $22.95M. Over the past 30 days, its market cap has decreased by -12.94%, while in the last 12 months, it has decreased by -8.3%.

Market capitalization represents the total value of Caladrius Biosciences as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Caladrius Biosciences (CLBS) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Caladrius Biosciences (CLBS) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Caladrius Biosciences (CLBS) Market Cap History

DateMarket CapChange
Aug 1, 2025$21.41M-12.94%
Jul 1, 2025$24.60M+4.38%
Jun 2, 2025$23.56M+13.40%
May 1, 2025$20.78M+11.57%
Apr 1, 2025$18.62M+0.47%
Mar 3, 2025$18.54M-14.43%
Feb 3, 2025$21.66M-27.73%
Jan 2, 2025$29.97M+28.88%

Caladrius Biosciences (CLBS) End of Year Market Cap History

DateMarket CapChange
2025$22.95M-8.30%
2024$25.02M+12.58%
2023$22.23M+11.75%
2022$19.89M-60.48%
2021$50.32M+81.58%
2020$27.72M

FAQs About Caladrius Biosciences (CLBS) Market Cap

As of Aug 12, 2025, the market capitalization of Caladrius Biosciences (CLBS) is $22.95M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Caladrius Biosciences’s market capitalization has decreased by -1.55%, changing from $23.31M to $22.95M as of Aug 12, 2025.

In the last 3 months, Caladrius Biosciences’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Caladrius Biosciences’s market capitalization increased from $22.23M in January to $25.02M in December, reflecting a 12.58% change.

In the past five years, Caladrius Biosciences (CLBS) has had a compound annual growth rate (CAGR) of -2.02% in market capitalization. This means its market cap has shrunk at an average rate of -2.02% per year.

Caladrius Biosciences (CLBS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.